We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Uncertain Benefit for Imaging After Thyroid Cancer Treatment

By MedImaging International staff writers
Posted on 03 Aug 2016
Print article
Image: A new study suggests imaging tests following primary treatment of differentiated thyroid cancer rarely leads to an improvement in chances of survival (Photo courtesy of the University of Michigan).
Image: A new study suggests imaging tests following primary treatment of differentiated thyroid cancer rarely leads to an improvement in chances of survival (Photo courtesy of the University of Michigan).
Researchers at the University of Michigan (Ann Arbor, USA) conducted a surveillance epidemiological study of 28,220 patients diagnosed with differentiated thyroid cancer between 1998 and 2011. The study cohort was followed up to 2013, with a median follow-up of 69 months. Following treatment, 56.7% of the patients had at least one ultrasound, 23.9% had a radioiodine scan, and 14.9% had a positron emission tomography (PET) scan to monitor for signs of cancer recurrence. The main outcome measures were treatment for recurrence of differentiated thyroid cancer and death.

The results showed that patients who underwent imaging were more likely to undergo further treatment, such as additional neck surgery, additional radioactive iodine treatment, or radiotherapy. The researchers also found that while the use of neck ultrasounds or PET scans did not significantly affect disease-specific survival, radioiodine scans were associated with an improved disease-specific survival. The study was published on July 20, 2016, in BMJ.

“Over time, we have seen this marked increase in the use of imaging after primary treatment of thyroid cancer, despite the fact that the majority of our patients have low-risk cancer. For the most part, this imaging isn't affecting survival,” concluded senior author assistant professor of medicine Megan Haymart, MD, and colleagues. “With the exception of radioiodine scans in presumed iodine avid disease, this association has shown no clear improvement in disease specific survival. These findings emphasize the importance of curbing unnecessary imaging and tailoring imaging after primary treatment to patient risk.”

Differentiated thyroid cancer has been increasing in incidence for several decades, and is expected to be the fourth leading cancer diagnosis by the year 2030; most of this rise is explained by diagnoses of small, low risk cancers, which are associated with an excellent long-term survival. Despite this, imaging tests after primary treatment of thyroid cancer is also rising, for reasons as yet unknown.

Related Links:
University of Michigan


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Digital Radiography Acquisition Software
VXvue with PureImpact
New
PACS Workstation
CHILI Web Viewer
Ultrasound System
P25 Elite

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.